Is Laps of Time Since Malaria Elimination a Factor in COVID-19 Mortality?

Authors

DOI:

https://doi.org/10.48112/bcs.v1i2.97

Abstract

Abstract Views: 111

Malaria can elicit a non-specific immune response against viral, bacterial and other malarial and non-malarial infections. Early in this pandemic suggestions were raised for possible role of cross immunity induced by malaria or other agents against SARS-CoV-2 severity. A possible role of heterogeneous immunity generated by previous malaria infection was suggested to explain part of diversity in COVID-19 mortality among various countries. This study was designed to examine this hypothesis by  looking  for possible statistical relation between malaria elimination date and COVID-19 mortality. Sixty -nine malaria-free countries with a total population of 1 million or more were enrolled in this study using robust statistical tests which include: Mann-Whitney Test, Kendall's-τ coefficient test and receiver operation characteristic - (ROC) curve analyses. Results showed that there was  a significant   negative association  among studied marker (COVID -19 deaths/million inhabitant , and date of elimination of malaria (using Kendall's-τ Correlation Coefficient test). There was a significant positive association between COVID-19 mortality and duration of time since the time of malaria elimination. With a cutoff point of 15, countries that eliminate malaria during the last 15 years had reduced median  COVID-19 mortality, while countries that eliminate malaria more than 15 years ago there is high COVID-19 median  mortality p value <0.05) . Receiver operation characteristic - (ROC) curve, was used to support these findings ( P value <0.05). The author of this article suggests that a correlation exists between malaria elimination duration and mortality due to COVID-19.

Keywords:

COVID-19, Cross immunity, Malaria, Non malarious countries, SARS-COV2

Metrics

Metrics Loading ...

References

Ahmed, A. E. (2020). Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections. Travel Medicine and Infectious Disease, 37, 101693-101693. https://dx.doi.org/10.1016%2Fj.tmaid.2020.101693

Al-Momen, H., Raham, T. F., & Daher, A. M. (2020). Tuberculosis versus COVID-19 Mortality: A New Evidence. Open Access Macedonian Journal of Medical Sciences, 8(T1), 179-183. https://doi.org/10.3889/oamjms.2020.5248

Alsulaiman, J. W., Khasawneh, A. I., & Kheirallah, K. A. (2020). Could “trained immunity” be induced by live attenuated vaccines protect against COVID-19? Review of available evidence. The Journal of Infection in Developing Countries, 14(09), 957-962. https://doi.org/10.3855/jidc.12805

Baluku, J. B., Nassozi, S., Gyagenda, B., Namanda, M., Andia-Biraro, I., Worodria, W., & Byakika-Kibwika, P. (2019). Prevalence of Malaria and TB Coinfection at a National Tuberculosis Treatment Centre in Uganda. Journal of tropical medicine, 2019, 3741294. https://doi.org/10.1155/2019/3741294

Banerjee, S., & Saha, A. (2020). Finding Tentative Causes for the reduced impact of Covid-19 on the Health Systems of poorer and developing nations: An ecological study of the effect of demographic, climatological and health-related factors on the global spread of Covid-19. medRxiv. https://doi.org/10.1101/2020.05.25.20113092

Beretta, A., Cranage, M., & Zipeto, D. (2020). Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.567710

Cernovsky, Z.Z. , Fernando, L.M.D., & Chiu, S. (2020). BCG Immunization Appears to Explain 26% of Variance in Cases of Covid19 per Capita. Archives of Community and Family Medicine, 3, (1), 23-27.

Cohen, J. (2019). Waning immunity. Science (New York, NY), 364(6437), 224-227. https://doi.org/10.1126/science.364.6437.224

Darwin, C. (1859). On the origin of species by means of natural selection, or the preservation of favoured races in the struggle for life. John Murray.

Edridge, A. W., Kaczorowska, J., Hoste, A. C., Bakker, M., Klein, M., Loens, K., ... & van der Hoek, L. (2020). Seasonal coronavirus protective immunity is short-lasting. Nature medicine, 26(11), 1691-1693.

Gomes, L. R., Martins, Y. C., Ferreira-da-Cruz, M. F., & Daniel-Ribeiro, C. T. (2014). Autoimmunity, phospholipid-reacting antibodies and malaria immunity. Lupus, 23(12), 1295-1298. https://doi.org/10.1177/0961203314546021

Gregory, T. R. (2009). Understanding natural selection: essential concepts and common misconceptions. Evolution: Education and outreach, 2(2), 156-175. https://doi.org/10.1007/s12052-009-0128-1

Guha, R., Mathioudaki, A., Doumbo, S., Doumtabe, D., Skinner, J., Arora, G., ... & Crompton, P. D. (2021). Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype. PLoS Pathogens, 17(4), e1009430. https://doi.org/10.1371/journal.ppat.1009430

Iwasaki, A. (2021). What reinfections mean for COVID-19. The Lancet infectious diseases, 21(1), 3-5. https://doi.org/10.1016/S1473-3099(20)30783-0

Kubota, Y., Shiono, T., Kusumoto, B., & Fujinuma, J. (2020). Multiple drivers of the COVID-19 spread: The roles of climate, international mobility, and region-specific conditions. PloS one, 15(9), e0239385. https://doi.org/10.1371/journal.pone.0239385

Merrill, R. M. (2013). Introduction to Epidemiology. Jones & Bartlett Publishers.

Murphy, J. R. (1980). Host defenses in murine malaria: Immunological characteristics of a protracted state of immunity to Plasmodium yoelii. Infection and Immunity, 27(1), 68-74. https://doi.org/10.1128/iai.27.1.68-74.1980

Napoli, P. E., & Nioi, M. (2020). Global spread of coronavirus disease 2019 and malaria: an epidemiological paradox in the early stage of a pandemic. Journal of clinical medicine, 9(4), 1138. https://doi.org/10.3390/jcm9041138

Neghina, R., Iacobiciu, I., Neghina, A. M., & Marincu, I. (2010). Malaria, a journey in time: in search of the lost myths and forgotten stories. The American journal of the medical sciences, 340(6), 492-498. https://doi.org/10.1097/MAJ.0b013e3181e7fe6c

Netea, M. G., Domínguez-Andrés, J., Barreiro, L. B., Chavakis, T., Divangahi, M., Fuchs, E., ... & Latz, E. (2020). Defining trained immunity and its role in health and disease. Nature Reviews Immunology, 20(6), 375-388. https://doi.org/10.1038/s41577-020-0285-6

Netea, M. G., Quintin, J., & Van Der Meer, J. W. (2011). Trained immunity: a memory for innate host defense. Cell host & microbe, 9(5), 355-361. https://doi.org/10.1016/j.chom.2011.04.006

O Murchu, E., Byrne, P., Walsh, K. A., Carty, P. G., Connolly, M., De Gascun, C., ... & Harrington, P. (2021). Immune response following infection with SARS‐CoV‐2 and other coronaviruses: a rapid review. Reviews in medical virology, 31(2), e2162. https://doi.org/10.1002/rmv.2162

Page, K. R., Jedlicka, A. E., Fakheri, B., Noland, G. S., Kesavan, A. K., Scott, A. L., ... & Manabe, Y. C. (2005). Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infection and immunity, 73(12), 8369-8380. https://doi.org/10.1128/IAI.73.12.8369-8380.2005

Parodi, A., & Cozzani, E. (2020). Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?. Medical hypotheses, 143, 110036. https://dx.doi.org/10.1016%2Fj.mehy.2020.110036

Perez-Mazliah, D., & Langhorne, J. (2014). CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol 5: 671. https://doi.org/10.3389/fimmu.2014.00671

Raham, T. F. (2020). Impact of duration of cessation of mass BCG vaccination programs on covid-19 mortality. medRxiv. https://doi.org/10.1101/2020.08.20.20178889

Raham, T. F. (2020). TB Prevalence Influence on Covid-19 Mortality. medRxiv. https://doi.org/10.1101/2020.05.05.20092395

Raham, T. F. (2021). Does Latent Tuberculosis Lead to a Spurious Correlation between BCG and COVID-19 Mortality?. Research Square. https://doi.org/10.21203/rs.3.rs-1138086/v1

Raham, T. F. (2021). Influence of malaria endemicity and tuberculosis prevalence on COVID-19 mortality. Public Health, 194, 33-35. https://doi.org/10.1016/j.puhe.2021.02.018

Raham, T. F. (2021). Tuberculosis Prevalence Correlation to COVID-19 Mortality in Malaria Free Countries. Research Square. https://doi.org/10.21203/rs.3.rs-1138806/v1

Rooth, I. B., & Bjorkman, A. (1992). Suppression of Plasmodium falciparum infections during concomitant measles or influenza but not during pertussis. The American journal of tropical medicine and hygiene, 47(5), 675-681. https://doi.org/10.4269/ajtmh.1992.47.675

Rosenzweig, M. L., & McCord, R. D. (1991). Incumbent replacement: evidence for long-term evolutionary progress. Paleobiology, 17(3), 202-213. https://doi.org/10.1017/S0094837300010563

Shretta, R., Liu, J., Cotter, C., Cohen, J., Dolenz, C., Makomva, K., ... & Feachem, R. (2017). Malaria Elimination and Eradication. Major Infectious Diseases.

The malERA Consultative Group on Drugs (2011) A Research Agenda for Malaria Eradication: Drugs. PLOS Medicine 8(1): e1000402. https://doi.org/10.1371/journal.pmed.1000402

Waitumbi, J. N., Kuypers, J., Anyona, S. B., Koros, J. N., Polhemus, M. E., Gerlach, J., ... & Domingo, G. J. (2010). Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya. The American journal of tropical medicine and hygiene, 83(5), 1010. https://dx.doi.org/10.4269%2Fajtmh.2010.10-0174

Wernsdorfer, W. H., & Kouznetsov, R. L. (1980). Drug-resistant malaria--occurrence, control, and surveillance. Bulletin of the World Health Organization, 58(3), 341.

Is Laps of Time Since Malaria Elimination a Factor in COVID-19 Mortality?

Published

2022-04-01

How to Cite

Raham, T. F. (2022). Is Laps of Time Since Malaria Elimination a Factor in COVID-19 Mortality?. Biomedicine and Chemical Sciences, 1(2), 65–69. https://doi.org/10.48112/bcs.v1i2.97

Issue

Section

Articles